The page is the record's research on the issuer — no analyst, no rating, no view. # GENMAB A/S (NASDAQ: GMAB) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is GENMAB A/S, listed on NASDAQ under ticker GMAB, with ISIN US3723032062 and LEI 529900MTJPDPE4MHJ122. Its security type is recorded as non-operating entity type (other). Its segment is not on the record, and its sector is 2834 Pharmaceutical Preparations. Its jurisdiction is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 80 filings in the window 2025-11-08 to 2026-11-08, across 63 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-05, is of type results, and is 3 days before the record date of 2026-11-08. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings count is 63.0, and the median latency is 4.0 days across 526 issuers. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag. Its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date of 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://data.sec.gov/submissions/CIK0001434265.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/GMAB (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/GMAB (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/GMAB · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp